Evidence for systemic rather than pulmonary effects of interleukin-5 administration in asthma

Thorax

Volumn 56, Issue 12, 2001, Pages 935-940

  Van Rensen, E L J ^a,b   Stirling, R G ^a   Scheerens, J ^a   Staples, K ^a   Sterk, P J ^b   Barnes, P J ^a   Chung, K F ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Asthma; Bronchial responsiveness; Eosinophil; Interleukin 5

Indexed keywords

EOTAXIN; PLACEBO; RECOMBINANT INTERLEUKIN 5;

ADULT; ARTICLE; ASTHMA; BRONCHUS REACTIVITY; CELL MOTILITY; CIRCULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFECT; EOSINOPHIL; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPUTUM ANALYSIS;

ADMINISTRATION, INHALATION; ADULT; ANALYSIS OF VARIANCE; ASTHMA; BRONCHIAL PROVOCATION TESTS; CELL COUNT; CHEMOKINES, CC; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INFUSIONS, INTRAVENOUS; INTERLEUKIN-5; MALE; PULMONARY EOSINOPHILIA; SPUTUM;

EID: 0035184832     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.56.12.935     Document Type: Article

References (40)

1. CD4 T-lymphocyte activation in asthma is accompanied by increased serum concentrations of interleukin-5. Effect of glucocorticoid therapy
2. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma
3. IL-5 and IL-5 receptor in asthma
4. Serum interleukin 5 concentrations in atopic and non-atopic patients with glucocorticoid-dependent chronic severe asthma
5. Bronchial mucosal expression of the genes encoding chemokines RANTES and MCP-3 in symptomatic atopic and nonatopic asthmatics: Relationship to the eosinophil-active cytokines interleukin (IL)-5, granulocyte macrophage-colony-stimulating factor, and IL-3
6. Kinetics of allergen-induced airway eosinophilic cytokine production and airway inflammation
7. Relationship between IL-4 and IL-5 mRNA expression and disease severity in atopic asthma
8. Effect of murine recombinant interleukin-5 on the cell population in guinea-pig airways
9. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo
10. α4 integrin-dependent eotaxin induction of bronchial hyperresponsiveness and eosinophil migration in interleukin-5 transgenic mice
11. The effect of IL-5 and eotaxin expression in the lung on eosinophil trafficking and degranulation and the induction of bronchial hyperreactivity
12. Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma
13. Effect of inhaled interleukin-5 on number and activity of eosinophils in circulation from asthmatics
14. Effect of inhaled interleukin-5 on airway hyperreactivity and eosinophilia in asthmatics
15. Bone marrow progenitors in allergic airways diseases: Studies in canine and human models
16. Regulation of IL-5 and IL-5 receptor expression in the bone marrow of allergic asthmatics
17. Lung volumes and forced ventilatory flows
18. Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults
19. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD
20. Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice
21. Rapid and selective induction of blood eosinophilia in guinea pigs by recombinant human interleukin 5
22. Effect of methacholine challenge on cellular composition of sputum induction
23. Effect of repeated sputum induction on cell counts in normal volunteers
24. Circulating, but not local lung, IL-5 is required for the development of antigen-induced airways eosinophilia
25. Effects of an interleukin blocking monoclonal antibody on eosinophils, airway hyperresponsiveness, and the late asthmatic response
26. Effect of anti-IL-5 monoclonal antibody on allergic bronchial eosinophilia and airway hyperresponsiveness in mice
27. Effect of Sch 55700, a humanized monoclonal antibody to human interleukin-5, on eosinophilic responses and bronchial hyperreactivity
28. The role of interleukin-5 (IL-5) in allergic airway hyperresponsiveness in mice
29. Anti-interleukin 5 but not anti-IgE prevents airway inflammation and airway hyperresponsiveness
30. Effects of an antibody to interleukin-5 in a monkey model of asthma
31. TRFK-5 reverses established airway eosinophilia but not established hyperresponsiveness in a murine model of chronic asthma
32. Evaluation of airway hyperreactivity in interleukin-5 transgenic mice
33. Role of mast cells, eosinophils and IL-5 in the development of airway hyperresponsiveness in sensitized mice
34. Report on the first nationwide survey of the distribution of human parasites in China. 1. Regional distribution of parasite species
35. Activated eosinophils are the major source of Th2-associated cytokines in the schistosome granuloma
36. Eosinophil chemoattractants generated in vivo
37. An essential role for interleukin-5 and eosinophils in helminth-induced airway hyperresponsiveness
38. The relationship between airways inflammation and asthma severity
39. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model
40. Cellular and molecular mechanisms involved in the regulation of eosinophil trafficking in vivo